- Home
- XGN vs MGRM Comparison
XGN vs MGRM Comparison
Compare XGN & MGRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XGN
- MGRM
- Stock Information
- Founded
- XGN 2002
- MGRM 2016
- Country
- XGN United States
- MGRM United States
- Employees
- XGN N/A
- MGRM N/A
- Industry
- XGN Medical Specialities
- MGRM Medical/Dental Instruments
- Sector
- XGN Health Care
- MGRM Health Care
- Exchange
- XGN Nasdaq
- MGRM Nasdaq
- Market Cap
- XGN 72.3M
- MGRM 66.9M
- IPO Year
- XGN 2019
- MGRM N/A
- Fundamental
- Price
- XGN $5.65
- MGRM $2.87
- Analyst Decision
- XGN Buy
- MGRM
- Analyst Count
- XGN 1
- MGRM 0
- Target Price
- XGN $7.00
- MGRM N/A
- AVG Volume (30 Days)
- XGN 189.6K
- MGRM 82.0K
- Earning Date
- XGN 11-12-2024
- MGRM 11-14-2024
- Dividend Yield
- XGN N/A
- MGRM N/A
- EPS Growth
- XGN N/A
- MGRM N/A
- EPS
- XGN N/A
- MGRM N/A
- Revenue
- XGN $55,751,000.00
- MGRM $364,999.00
- Revenue This Year
- XGN $6.74
- MGRM N/A
- Revenue Next Year
- XGN $17.32
- MGRM N/A
- P/E Ratio
- XGN N/A
- MGRM N/A
- Revenue Growth
- XGN 8.00
- MGRM N/A
- 52 Week Low
- XGN $1.30
- MGRM $1.53
- 52 Week High
- XGN $6.22
- MGRM $4.90
- Technical
- Relative Strength Index (RSI)
- XGN 74.82
- MGRM 71.37
- Support Level
- XGN $5.60
- MGRM $2.13
- Resistance Level
- XGN $6.22
- MGRM $2.84
- Average True Range (ATR)
- XGN 0.48
- MGRM 0.19
- MACD
- XGN 0.13
- MGRM 0.08
- Stochastic Oscillator
- XGN 88.00
- MGRM 91.34
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.